Pulmonology Xagena

Xagena Mappa
Xagena Newsletter
Medical Meeting

Search results for "Symbicort"

Results from the COSMOS trial demonstrated that Symbicort Single Inhaler Therapy, ( Budesonide / Formoterol maintenance and reliever therapy ), reduces the risk of severe asthma attack by 25 per ce ...

The use of a class of asthma drugs known as long-acting beta-2 agonists is associated with increased risks of asthma-related deaths. The asthma medications are Salmeterol, which is sold under th ...

In mild asthma exercise-induced bronchoconstriction is usually treated with inhaled short-acting beta2-agonists ( SABAs ) on demand. The hypothesis was that a combination of Budesonide and Formoter ...